参考文献/References:
[1] 白雅雯, 麻春杰. 炎症因子在IgA 肾病中的研究进展[J]. 中国现代医学杂志, 2023, 33(3): 63-68. BAI Yawen, MA Chunjie. Research advances of inflammatory cytokines in IgA nephropathy[J]. China Journal of Modern Medicine, 2023, 33(3): 63-68.
[2] RAJASEKARAN A, JULIAN B A, RIZK D V. IgA nephropathy: an interesting autoimmune kidney disease[J]. American Journal of the Medical Sciences,2021, 361(2): 176-194.
[3] CURRIE E G, COBURN B, PORFILIO E A, et al. Immunoglobulin a nephropathy is characterized by anticommensal humoral immune responses[J]. JCI Insight, 2022, 7(5): e141289.
[4] SIEBERT V, ALLENCHERRIL J, YE Yumei, et al. The role of non-coding RNAs in ischemic myocardial reperfusion injury[J]. Cardiovascular Drugs and Therapy, 2019, 33(4): 489-498.
[5] 柳越, 高艳超, 孙永艳, 等. circ0003204 靶向miR-346 对高糖诱导肾小管上皮细胞损伤的影响[J]. 现代医学, 2022, 50(7): 847-853. LIU Yue, GAO Yanchao, SUN Yongyan, et al. Effect of circ 0003204 targeting miR-346 on renal tubular epithelial cell damage induced by high glucose[J].Modern Medical Journal, 2022, 50(7): 847-853.
[6] 汤路路, 韩秋峪, 孟琳, 等. 血清SFRP4, SFRP5 与妊娠期糖尿病的相关性研究[J]. 医学研究杂志,2021, 50(5): 96-99. TANG Lulu, HAN Qiuyu, MENG Lin, et al. Correlation between the levels of serum SFRP4,SFRP5 and gestational diabetes mellitus[J]. Journal of Medical Research, 2021, 50(5): 96-99.
[7] 徐庆东, 郭焕开, 陈洁欣, 等. 血清SFRP-4 水平与2型糖尿病肾病患者胰岛素抵抗、肾功能及肾纤维化指标的相关性[J]. 疑难病杂志, 2021, 20(2): 158-162. XU Qingdong, GUO Huankai, CHEN Jiexin, et al. Correlation between serum SFRP-4 level and insulin resistance, renal function and renal fibrosis indexes in patients with type 2 diabetic nephropathy[J]. Chinese Journal of Difficult and Complicated Cases, 2021,20(2): 158-162.
[8] 马懿, 曾蜀春. IgA 肾病血清lncRNA lnc-TSI,lncRNA GAS5 表达及与病情程度的相关性分析[J].中国社区医师, 2022, 38(35): 84-86. MA Yi, ZENG Shuchun. Analysis of serum lncRNA lnc-TSI and lncRNA GAS5 expression in IgA nephropathy and correlation with the degree of disease[J]. Chinese Community Doctors, 2022, 38(35): 84-86.
[9] 吴旭, 吴炜飞, 程志群. 血清Gd-IgA1 与伴有中度蛋白尿的IgA 肾病的相关性分析[J]. 中国现代医生,2022, 60(16): 25-29. WU Xu, WU Weifei, CHENG Zhiqun. Correlation analysis between serum Gd-IgA1 and IgA nephropathy with moderate proteinuria[J]. China Modern Doctor,2022, 60(16): 25-29.
[10] 沈伟兴, 汤佳瑾, 傅鹏. 原发性IgA 肾病患者血清miR-181b 水平表达与病情严重程度及预后的相关性分析[J]. 现代检验医学杂志, 2021, 36(6): 51-54, 63. SHEN Weixing, TANG Jiajin, FU Peng. Analysis of the correlation between the expression of serum miR-181b and the severity and prognosis of patients with primary IgA nephropathy[J]. Journal of Modern Laboratory Medicine, 2021, 36(6): 51-54, 63.
[11] 韩艳, 高原小雪, 谢宇端. miR-29a,ET-1 在IgA 肾病患者血清中的表达及其临床意义[J]. 标记免疫分析与临床, 2021, 28(7): 1095-1099. HAN Yan, GAO YUAN xiaoxue, XIE Yuduan. Expressions and clinical significances of miR-29a and ET-1 in serum of patients with IgA nephropathy[J].Labeled Immunoassays and Clinical Medicine, 2021,28(7): 1095-1099.
[12] 张明威, 陈阳, 王静, 等. 肾细胞癌患者癌组织和血清微囊泡miR-378 表达水平的临床应用价值研究[J].现代检验医学杂志, 2022, 37(2): 1-5, 11. ZHANG Mingwei, CHEN Yang, WANG Jing, et al. Clinical value of miR-378 expression levels in tumor tissue and serum extracellular vesicles for renal cell carcinoma patients and its function prediction[J]. Journal of Modern Laboratory Medicine, 2022, 37(2): 1-5, 11.
[13] 黎志钦, 刘永达. 肾癌患者血清miR-23a-3p, miR-29a 表达变化及临床意义[J]. 山东医药, 2021,61(28): 58-61. LI Zhiqin, LIU Yongda. Expression changes and clinical significance of serum miR-23a-3p and miR-29a in patients with renal cancer[J]. Shandong Medical Journal, 2021, 61(28): 58-61.
[14] 周仕群, 王聪, 江强, 等. 糖尿病肾病患者血清miR-188-5p 及miR-379-5p 的表达及其临床意义[J]. 现代检验医学杂志, 2022, 37(3): 91-95. ZHOU Shiqun, WANG Cong, JIANG Qiang, et al. Expression and clinical significance of serum miR-188-5p and miR-379-5p in patients with diabetic nephropathy[J]. Journal of Modern Laboratory Medicine, 2022, 37(3): 91-95.
[15] SUN B, QU Z, CHENG G L, et al. Urinary microRNAs miR-15b and miR-30a as novel noninvasive biomarkers for gentamicin-induced acute kidney injury[J].Toxicology Letters, 2021, 338: 105-113.
[16] 陈程, 史硕, 麻雯熠, 等. 丝胶通过调节miR-346 表达对高糖致足细胞损伤的保护作用[J]. 中国老年学杂志, 2022, 42(19): 4716-4720. CHEN Cheng, SHI Shuo, MA Wenyi, et al. Protective effect of sericin on podocyte injury induced by high glucose through regulating miR-346[J]. Chinese Journal of Gerontology, 2022, 42(19): 4716-4720.
[17] SU Z H, LIAO H H, LU K E, et al. Hypoxia-responsive miR-346 promotes proliferation, migration, and invasion of renal cell carcinoma cells via targeting NDRG2[J]. Neoplasma, 2020, 67(5): 1002-1011.
[18] LI Haojie, ZHAO Junjie, SUN Jie, et al. Demethylation of the SFRP4 promoter drives gastric cancer progression via the Wnt pathway SFRP4 promotes gastric cancer progression[J]. Molecular Cancer Research, 2021, 19(9): 1454-1464.
[19] BUSUTTIL R A, GEORGE J, HOUSE C M, et al. SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence[J]. Gastric Cancer, 2021, 24(3):589-601.
[20] 金倩倩, 李华君, 王晓蕴, 等. 糖尿病肾病患者血清分泌型卷曲相关蛋白-4、脂氧素A4、趋化素的表达及意义[J]. 实用临床医药杂志, 2022, 26(21): 41-45, 64. JIN Qianqian, LI Huajun, WANG Xiaoyun, et al. Expression of significance of serum secreted frizzledrelated protein-4,lipoxygenase A4 and chemerin in patients with diabetic nephropathy[J]. Journal of Clinical Medicine In Practice, 2022, 26(21): 41-45, 64.
[21] 曹霖霖, 王鹏, 张琪, 等. 老年急性心力衰竭致不同分期急性肾损伤病人的临床特征及与P2Y14, SFRP4表达的相关性[J]. 中西医结合心脑血管病杂志,2023, 21(9): 1568-1573. CAO Linlin, WANG Peng, ZHANG Qi, et al. Clinical features and correlation with expression of P2Y14 and SFRP4 in aged patients with acute renal injury at different stages caused by acute heart failure[J].Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease, 2023, 21(9): 1568-1573.
[22] REN Xiaojun, ZHU Ruifang, LIU Gaohong, et al. Effect of sitagliptin on tubulointerstitial Wnt/β‐catenin signalling in diabetic nephropathy[J].Nephrology, 2019, 24(11): 1189-1197.